UnknownNot Applicable

Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

South Korea29 participantsStarted 2015-09

Plain-language summary

To compare the short-term effect of intravitreal aflibercept injection between two subtypes of polypoidal choroidal vasculopathy

Age range45 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. symptomatic typical PCV accompanying branch vascular network involving subfoveal area
✓. signed informed consent; and
✓. over 6 months follow-up period after enrollment.

✕. retinal diseases other than PCV
✕. extrafoveal PCV not involving subfoveal area
✕. massive subretinal hemorrhage blocking polypoidal lesion on ICGA
✕. severe media opacity such as senile cataract
✕. previous history of intravitreal injection
✕. previous intraocular surgery history except cataract surgery which was done more than 3 months.

Regression Rate of Polyp on Indocyanine Green Angiography

Timeframe: 3 months

NCT IDNCT02597855

SponsorYeungnam University College of Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-12

Results submitted2016-03-22